Trial Profile

A Phase III global multi-regional clinical trial of CS2009

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 14 Apr 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CS 2009 (Primary)
Indications Colorectal cancer; Non-small cell lung cancer; Small cell lung cancer
Focus Therapeutic Use

14 Apr 2026 New trial record
26 Mar 2026 According to CStone media release, the company plans to initiate the first set of Phase III global multi-regional clinical trials (MRCTs) for CS2009 by the end of 2026, focusing on indications including NSCLC, CRC, and SCLC. The company is currently into partnership discussions with several global multinational pharmaceutical companies and aim to initiate multiple Phase III MRCT by the end of 2026.
26 Mar 2026 According to CStone media release, company plan to initiate a Phase III global multi-regional clinical trial of CS2009 by the end of 2026

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com